Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ICOS | Q9Y6W8 | Inducible T-cell costimulator (Activation-inducible lymphocyte immunomediatory molecule) (CD antigen CD278) | CD markersDisease related genesHuman disease related genes | 1 | Lupus erythematosusSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 5 | 0.38 | ||
| LRC15 | Q8TF66 | Leucine-rich repeat-containing protein 15 (Leucine-rich repeat protein induced by beta-amyloid homolog) (hLib) | Plasma proteinsPredicted membrane proteinsTransporters | 1 | Fusion and delivery mediation | 5 | 0.38 | |||
| SL9A6 | Q92581 | Sodium/hydrogen exchanger 6 (Na(+)/H(+) exchanger 6) (NHE-6) (Solute carrier family 9 member 6) | Disease related genesHuman disease related genesPotential drug targets | 12 | Clinical-translation mediationFusion and delivery mediation | 5 | 0.38 | |||
| TNR5 | P25942 | Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40) | Cancer-related genesCD markersDisease related genes | 1 | Brain cancerCrohn diseaseDiabetes mellitus | Clinical-translation mediationFusion and delivery mediationImmune mediation | 5 | 0.38 | ||
| ACM4 | P08173 | Muscarinic acetylcholine receptor M4 | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | AsthmaAttention deficit hyperactivity disorderEye anterior segment structural developmental anomaly | Clinical-translation mediationReceptor-signaling mediation | 4 | 0.38 | ||
| MMP24 | Q9Y5R2 | Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24] | EnzymesPredicted membrane proteinsPredicted secreted proteins | 1 | Adhesion and uptake mediationFusion and delivery mediation | 4 | 0.38 | |||
| ULBP5 | Q6H3X3 | UL-16 binding protein 5 (Retinoic acid early transcript 1G protein) | 1 | Fusion and delivery mediationImmune mediationMetabolism mediation | 4 | 0.38 | ||||
| ADCY3 | O60266 | Adenylate cyclase type 3 (EC 4.6.1.1) (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III) (AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3) (AC3) | Disease related genesEnzymesHuman disease related genes | 12 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 3 | 0.38 | |||
| FSP1 | Q9BRQ8 | Ferroptosis suppressor protein 1 (FSP1) (EC 1.6.5.-) (Apoptosis-inducing factor homologous mitochondrion-associated inducer of death) (AMID) (p53-responsive gene 3 protein) | Predicted intracellular proteins | 1 | Other mediation | 3 | 0.38 | |||
| G6B | O95866 | Megakaryocyte and platelet inhibitory receptor G6b (Protein G6b) | 1 | Immune mediation | 3 | 0.38 | ||||
| GPR27 | Q9NS67 | Probable G-protein coupled receptor 27 (Super conserved receptor expressed in brain 1) | G-protein coupled receptorsPredicted membrane proteins | 7 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 3 | 0.38 | |||
| I11RA | Q14626 | Interleukin-11 receptor subunit alpha (IL-11 receptor subunit alpha) (IL-11R subunit alpha) (IL-11R-alpha) (IL-11RA) [Cleaved into: Soluble interleukin-11 receptor subunit alpha (sIL-11R) (sIL-11RA) (sIL11RA)] | Disease related genesFDA approved drug targetsHuman disease related genes | 1 | Prostate cancerThrombocytopenia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 3 | 0.38 | ||
| MET | P08581 | Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) | Cancer-related genesDisease related genesEnzymes | 1 | Alzheimer diseaseBiliary tract cancerBrain cancer | Clinical-translation mediationFusion and delivery mediationImmune mediation | 3 | 0.38 | ||
| MTR1L | Q13585 | Melatonin-related receptor (G protein-coupled receptor 50) (H9) [Cleaved into: C-terminal domain] | G-protein coupled receptorsPlasma proteinsPredicted membrane proteins | 7 | Other mediation | 3 | 0.38 | |||
| NCKPL | P55160 | Nck-associated protein 1-like (Hematopoietic protein 1) (Membrane-associated protein HEM-1) | Disease related genesHuman disease related genesPlasma proteins | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.38 | |||
| NPTXR | O95502 | Neuronal pentraxin receptor | Plasma proteinsPredicted intracellular proteins | 1 | Other mediation | 3 | 0.38 | |||
| NTRK2 | Q16620 | BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B) | Cancer-related genesDisease related genesEnzymes | 1 | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 3 | 0.38 | |||
| PECA1 | P16284 | Platelet endothelial cell adhesion molecule (PECAM-1) (EndoCAM) (GPIIA') (PECA1) (CD antigen CD31) | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 3 | 0.38 | |||
| PTPRH | Q9HD43 | Receptor-type tyrosine-protein phosphatase H (R-PTP-H) (EC 3.1.3.48) (Stomach cancer-associated protein tyrosine phosphatase 1) (SAP-1) (Transmembrane-type protein-tyrosine phosphatase type H) | 1 | Fusion and delivery mediationMetabolism mediation | 3 | 0.38 | ||||
| ACHA5 | P30532 | Neuronal acetylcholine receptor subunit alpha-5 | FDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins | 4 | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 2 | 0.38 | |||
| ANPRA | P16066 | Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) | 1 | AsthmaGeneral pain disorderHeart disease | Clinical-translation mediationReceptor-signaling mediation | 2 | 0.38 | |||
| CD8A | P01732 | T-cell surface glycoprotein CD8 alpha chain (T-lymphocyte differentiation antigen T8/Leu-2) (CD antigen CD8a) | CD markersDisease related genesHuman disease related genes | 1 | Fusion and delivery mediationImmune mediation | 2 | 0.38 | |||
| CXAR | P78310 | Coxsackievirus and adenovirus receptor (CAR) (hCAR) (CVB3-binding protein) (Coxsackievirus B-adenovirus receptor) (HCVADR) | Predicted membrane proteinsPredicted secreted proteinsTransporters | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 2 | 0.38 | |||
| FCMR | O60667 | Immunoglobulin mu Fc receptor (IgM FcR) (Fas apoptotic inhibitory molecule 3) (FAIM3) (Regulator of Fas-induced apoptosis Toso) | Predicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 2 | 0.38 | |||
| G37L1 | O60883 | G-protein coupled receptor 37-like 1 (Endothelin B receptor-like protein 2) (ETBR-LP-2) | G-protein coupled receptorsPredicted membrane proteins | 7 | Receptor-signaling mediation | 2 | 0.38 |